Advertisement
Screener

Applied Therapeutics, Inc. Patents: Applications Pending

Applied Therapeutics, Inc. Patent Applications Pending

20 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-12-10: Application 19414626; Invention INHIBITORS OF ALDOSE REDUCTASE; Applicant Applied Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2024-10-18: Application 63708948; Invention METHODS OF TREATING DIABETIC CARDIOMYOPATHY; Applicant APPLIED THERAPEUTICS, INC.; Status Provisional Application Expired.
  • 2024-02-01: Application 18429719; Invention ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL DEHYDROGENASE DEFICIENCY; Applicant APPLIED THERAPEUTICS, INC.; Status Allowed -- Notice of Allowance Not Yet Mailed.
  • 2023-01-23: Application 18158089; Invention COMPOSITIONS AND METHODS FOR TREATING GALACTOSEMIA; Applicant Applied Therapeutics, Inc.; Status Response to Non-Final Office Action Entered and Forwarded to Examiner.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-12-1019414626INHIBITORS OF ALDOSE REDUCTASEApplied Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260092072A1
Andrew WASMUTH
United States
CENTRAL, DOCKET
2024-10-1863708948METHODS OF TREATING DIABETIC CARDIOMYOPATHYAPPLIED THERAPEUTICS, INC.Provisional Application Expired
Riccardo Perfetti
Shoshana Shendelman
United States
United States
2024-02-0118429719ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL DEHYDROGENASE DEFICIENCYAPPLIED THERAPEUTICS, INC.Allowed -- Notice of Allowance Not Yet MailedUS20240238288A1
Shoshana SHENDELMAN
United States
MCMILLIAN, KARA RENITA
2023-01-2318158089COMPOSITIONS AND METHODS FOR TREATING GALACTOSEMIAApplied Therapeutics, Inc.Response to Non-Final Office Action Entered and Forwarded to ExaminerUS20230346782A1
Shoshana SHENDELMAN
United States
COLEMAN, BRENDA LIBBY
2022-09-2317951342ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY AND ANTI-VIRAL THERAPYApplied Therapeutics, Inc.Non Final Action MailedUS20230058134A1
Shoshana SHENDELMAN
United States
ROZOF, TIMOTHY R
2022-04-0717715401ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCYApplied Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20220226323A1
Riccardo Perfetti
Shoshana SHENDELMAN
United States
United States
MCMILLIAN, KARA RENITA
2021-04-27PCTUS2021029286ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL DEHYDROGENASE DEFICIENCYAPPLIED THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SHOSHANA SHENDELMAN
United States
2020-10-07PCTUS2020054607ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCYAPPLIED THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
SHOSHANA SHENDELMAN
RICCARDO PERFETTI
United States
United States
YOUNG, LEE W
2020-05-0463019738Aldose Reductase Inhibitors for Treating Sorbitol Dehydrogenase DeficiencyApplied Therapeutics, Inc.Provisional Application Expired
Shoshana SHENDELMAN
United States
2020-05-0163019186Aldose Reductase Inhibitors for Treating Sorbitol Dehydrogenase DeficiencyApplied Therapeutics, Inc.Provisional Application Expired
Shoshana SHENDELMAN
United States
2020-04-0763006264ALDOSE REDUCTASE INHIBITORS FOR ANTI-VIRAL THERAPYApplied Therapeutics, Inc.Provisional Application Expired
Shoshana SHENDELMAN
United States
2020-03-31PCTUS2020025928INHIBITORS OF ALDOSE REDUCTASEAPPLIED THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ANDREW WASMUTH
United States
2020-03-3163002538ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF ACUTE RESPIRATROY DISTRESS SYNDROME, ACUTE LUNG INFLAMATION/INJURY AND CARDIAC INJURYApplied Therapeutics, Inc.Provisional Application Expired
Shoshana SHENDELMAN
United States
2020-02-12PCTUS2020017913METHODS FOR TREATING CUTANEOUS AGINGAPPLIED THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
SHOSHANA SHENDELMAN
United States
THOMAS, SHANE M
2019-10-3162928735INHIBITORS OF ALDOSE REDUCTASEAPPLIED THERAPEUTICS INC.Provisional Application Expired
Andrew Wasmuth
United States
2019-10-0862912441ALDOSE REDUCTASE INHIBITORS FOR TREATEMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCYAPPLIED THERAPEUTICS INC.Provisional Application Expired
Riccardo PERFETTI
Shoshana SHENDELMAN
United States
United States
2019-02-1262804413METHODS FOR TREATING CUTANEOUS AGINGAPPLIED THERAPEUTICS INC.Provisional Application Expired
Shoshana SHENDELMAN
United States
2018-07-27PCTUS2018044199COMPOSITIONS AND METHODS FOR TREATING GALACTOSEMIAAPPLIED THERAPEUTICS INC.PCT - International Search Report Mailed to IB
SHOSHANA SHENDELMAN
United States
YOUNG, LEE W
2018-04-17PCTUS2018027960ALDOSE REDUCTASE INHIBITORS AND USES THEREOFAPPLIED THERAPEUTICS INC.PCT - International Search Report Mailed to IB
SHOSHANA SHENDELMAN
United States
YOUNG, LEE W
2017-04-2762491243Aldose Reductase InhibitorsApplied Therapeutics Inc.Provisional Application Expired
Shoshana Shendelman
United States